Publicaciones científicas

21 Publicaciones científicas disponibles

  • EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

    12 de septiembre de 2019 | Revista: Hepatology

    Gouya L (1), Ventura P (2), Balwani M (3), Bissell DM (4), Rees DC (5), Stölzel U (6), Phillips JD (7), Kauppinen R (8), Langendonk JG (9), Desnick RJ (3), Deybach JC (1), Bonkovsky HL (10), Parker C (7), Naik H (3), Badminton M (11), Stein PE (5), Minder E (12), Windyga J (13), Bruha R (14), Cappellini MD (15), Sardh E (16), Harper P (16), Sandberg S (17), Aarsand AK (17), Andersen J (17), Alegre F (18), Ivanova A (19), Talbi N (20), Chan A (21), Querbes W (21), Ko J (21), Penz C (21), Liu S (21), Lin T (21), Simon A (21), Anderson KE (22).

    (1) Centre de Référence Maladies Rares Porphyries, Colombes, France.
    (2) Università degli Studi di Modena e Reggio Emilia, Emilia-Romagna, Italy.
    (3) Icahn School of Medicine at Mount Sinai, New York, NY, USA.
    (4) University of California, San Francisco, CA, USA.
    (5) King's College Hospital, King's College London, London, UK.
    (6) Klinikum Chemnitz Porphyria Center, Chemnitz, Germany.
    (7) University of Utah, Salt Lake City, UT, USA.
    (8) University Hospital of Helsinki, Helsinki, Finland.
    (9) Porphyria Center, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
    (10) Section on Gastroenterology & Hepatology, Wake Forest University/NC Baptist Medical Center, Winston-Salem, NC, USA.
    (11) University Hospital of Wales, Cardiff, UK.
    (12) Stadtspital Triemli, Zentrallabor, Zurich, Switzerland.
    (13) Department of Hemostatic Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
    (14) 4th internal clinic, General University Hospital, Charles University, Prague, Czech republic.
    (15) University of Milan, Fondazione IRCCS, Ca Granda, Milan, Italy.
    (16) Porphyria Centre Sweden, Centre for Inherited Metabolic Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    (17) Norwegian Porphyria Centre, Haukeland University Hospital, Bergen, Norway.
    (18) Clinica Universidad de Navarra, Navarra, Spain.
    (19) St. Ivan Rilski U Hospital, Sofia, Bulgaria.
    (20) Laboratory of Excellence GR-Ex, University of Paris, Paris, France.
    (21) Alnylam Pharmaceuticals, Cambridge, MA, USA.
    (22) University of Texas Medical Branch, Galveston, TX, USA


  • Lercanidipine-induced chylous ascites: Case report and literature review

    2 de octubre de 2017 | Revista: Journal of Clinical of Pharmacy Therapeuthics

    Basualdo JE (1), Rosado IA (1), Morales MI (2), Fernández-Ros N (1), Huerta A (1), Alegre F (1), Landecho MF (1), Lucena JF (1).

    (1) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.


  • Enterococcal bloodstream infection. Design and validation of a mortality prediction rule

    1 de febrero de 2016 | Revista: International Journal of Clinical Practice

    Pérez-García A (1), Landecho MF (2), Beunza JJ (3), Conde-Estévez D (4), Horcajada JP (5), Grau S (4), Gea A (6), Mauleón E (7), Sorli L (5), Gómez J (8), Terradas R (9), Lucena JF (2), Alegre F (2), Huerta A (2), Del Pozo JL (10).
    (1) Department of Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, Pamplona, Spain.
    (3) Interdusciplinar Education, Universidad Europea, Pamplona, Spain.
    (4) Service of Pharmacy, Hospital Universitari del Mar, Barcelona, Spain.
    (5) Service of Infectious diseases, Hospital Universitari del Mar, Institut Hospital del Mar d'Investigacions Médiques, CEXS-Universitat Pompeu Fabra, CIBERES, Barcelona, Spain.
    (6) Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
    (7) Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (8) Depatament of Microbiology, Laboratori de Referencia de Catalunya, Barcelona, Spain.
    (9) Service of Evaluation and Clinical Epidemiology, Hospital Universitari del Mar, Barcelona, Spain.
    (10) Division of Infectious diseases, Department Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain. 


  • Comment on "Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit" by Benoît Dupont et al.

    1 de febrero de 2016 | Revista: Digestive and Liver Disease

    Alegre F (1), Huerta A (2), Landecho MF (2), Lucena JF (2).
    (1) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. Electronic address: falegre@unav.es.
    (2) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.